MedTrace Logo

Evaluation of the Safety and Efficacy of Rigid Breathable Scleral Contact Lenses for the Correction of Ametropia

NCT06256770 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 176

Last updated 2024-02-13

No results posted yet for this study

Summary

To evaluate the short-term efficacy and safety of scleral contact lens in the clinical treatment of patients with irregular astigmatism after corneal transplantation by analyzing ocular parameters and ocular surface conditions of patients after corneal transplantation.

Conditions

  • Ocular Surface Disease
  • Irregular Astigmatism
  • Contact Lens Complication
  • Corneal Astigmatism

Sponsors & Collaborators

  • Tianjin Eye Hospital

    lead OTHER

Principal Investigators

  • Yan Wang, Prof · Tianjin Eye Hospital

Eligibility

Min Age
8 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-11-01
Primary Completion
2024-09-01
Completion
2024-12-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06256770 on ClinicalTrials.gov